| Erectile aid use by men treated for localized prostate cancer. | |
| | |
MedLine Citation:
|
PMID: 19535108 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: We evaluated associations between demographic and clinical characteristics, quality of life outcome measures and erectile aids in men treated for localized prostate cancer. MATERIALS AND METHODS: Patients had clinically localized prostate cancer, were not using erectile aids at baseline and chose treatment with radical prostatectomy (275), external beam radiotherapy (70) or brachytherapy (80). Patient characteristics and health related quality of life outcomes were prospectively assessed at baseline and at regular intervals up to 48 months after treatment. Outcomes were assessed with SF-36, the American Urological Association symptom index and UCLA-PCI. We categorized use of a phosphodiesterase type 5 inhibitor, urethral alprostadil suppositories, penile injection therapy or a vacuum erection device after treatment as erectile aid use. We created a multivariate model examining baseline demographic, clinical and health related quality of life covariates associated with erectile aid use. RESULTS: Of the 425 patients 237 (56%) used an erectile aid at some point during the posttreatment period. In our multivariate model patients treated with external beam radiation were less likely to use an aid (OR 0.34, 95% CI 0.16-0.69) and men with significant sexual bother (OR 2.68, 95% CI 1.37-5.23), or with 1 or more comorbidities (OR 1.80, 95% CI 1.08-2.93) were more likely to use an aid. Patient demographic characteristics were not associated with erectile aids. CONCLUSIONS: After treatment for localized prostate cancer more than half of men use erectile aids, especially when they are significantly bothered by dysfunction. This is most pronounced after radical prostatectomy and in men with significant comorbidity. |
| | |
Authors:
|
Jonathan Bergman; John L Gore; David F Penson; Lorna Kwan; Mark S Litwin |
Related Documents
:
|
9222578 - Model for assessing psychosocial problems. 2705068 - Aids and student attitudes. 20963318 - Molecular diagnosis of cerebral toxoplasmosis: comparing markers that determine toxopla... 8902068 - Intestinal inflammation, ileal structure and function in hiv. 9387828 - Setting standards and defining quality of performance in the validation of a standardiz... 1842278 - Measurement of performance of a peripheral vision lipreading aid. |
Publication Detail:
|
Type: Journal Article Date: 2009-06-17 |
Journal Detail:
|
Title: The Journal of urology Volume: 182 ISSN: 1527-3792 ISO Abbreviation: J. Urol. Publication Date: 2009 Aug |
Date Detail:
|
Created Date: 2009-07-14 Completed Date: 2009-08-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0376374 Medline TA: J Urol Country: United States |
Other Details:
|
Languages: eng Pagination: 649-54 Citation Subset: AIM; IM |
Affiliation:
|
Department of Urology, University of California-Los Angeles, Los Angeles, California 90095-1738, USA. jbergman@mednet.ucla.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Erectile Dysfunction / therapy* Humans Male Middle Aged Prospective Studies Prostatic Neoplasms / therapy Self-Help Devices |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mixed urinary incontinence: greater impact on quality of life.
Next Document: A method to improve patient access in urological practice.